Literature DB >> 19441992

Percutaneous tumor curettage and interstitial delivery of samarium-153 coupled with kyphoplasty for treatment of vertebral metastases.

Erico R Cardoso1, Hani Ashamalla, Lijun Weng, Bahaa Mokhtar, Shamsah Ali, Mark Macedon, Adel Guirguis.   

Abstract

OBJECT: The object of this study was to investigate the use of a minimally invasive technique for treating metastatic tumors of the vertebral body, aimed at relieving pain, preventing further tumor growth, and minimizing the adverse effects of systemic use of samarium-153 ((153)Sm).
METHODS: The procedure is performed in the same fashion as a kyphoplasty, using a unilateral extrapedicular approach under local anesthesia/mild general sedation, with the patient in the lateral decubitus position. The tumor is accessed as in a standard kyphoplasty. The side is chosen according to the location of the metastasis. Prior to inflation of the balloon the tumor is debulked by percutaneous curettage. Balloon inflation is carried out as per standard kyphoplasty in an attempt to create a larger space and reduce a possible kyphotic deformity. Three mCi of (153)Sm-EDTMP (ethylenediaminetetramethylenephosphonic acid) is then mixed with bone cement (polymethylmethacrylate) and injected into the void created by the balloon tamp.
RESULTS: Twenty-four procedures were performed in 19 patients. There was reliable and reproducible delivery of the radiolabeled (153)Sm-EDTMP to the metastatic site, without spillage. The procedure was safe. There were no procedure-related complications. There was no hematological toxicity with the low doses of (153)Sm used. Pain improved in all patients. The long-term results related to tumor control continue to be investigated.
CONCLUSIONS: Combined percutaneous debulking of confined vertebral metastases and administration of local (153)Sm is feasible and safe. Furthermore, this technique leads to immediate relief of cancer-related pain and may help prevent or slow down the progression of vertebral metastatic tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19441992     DOI: 10.3171/2008.11.SPINE0856

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  7 in total

Review 1.  Image-Guided Bone Consolidation in Oncology.

Authors:  Xavier Buy; Vittorio Catena; Guilhem Roubaud; Amandine Crombe; Michèle Kind; Jean Palussiere
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

2.  Kypho-IORT--a novel approach of intraoperative radiotherapy during kyphoplasty for vertebral metastases.

Authors:  Frederik Wenz; Frank Schneider; Christian Neumaier; Uta Kraus-Tiefenbacher; Tina Reis; René Schmidt; Udo Obertacke
Journal:  Radiat Oncol       Date:  2010-02-11       Impact factor: 3.481

3.  [Kyphoplasty combined with intraoperative radiotherapy (Kypho-IORT). Alternative therapy for patients with oligometastatic spinal metastases].

Authors:  F Bludau; T Reis; F Schneider; S Clausen; F Wenz; U Obertacke
Journal:  Radiologe       Date:  2015-10       Impact factor: 0.635

4.  A preliminary safety assessment of vertebral augmentation with32P brachytherapy bone cement.

Authors:  Joyce H Keyak; Mando L Eijansantos; Katherine G Rosecrance; Daniel Wong; Sayeh Feizi; Aleen L Meldosian; Pranav Peddinti; Clifford M Les; Harry B Skinner; Varun Sehgal
Journal:  Phys Med Biol       Date:  2022-04-01       Impact factor: 4.174

5.  Electron beam intraoperative radiotherapy for metastatic epidural spinal cord compression: a prospective observational study.

Authors:  Kei Ito; Shurei Sugita; Yujiro Nakajima; Takahiro Hozumi; Kiyofumi Yamakawa; Masanori Fujiwara; Katsuyuki Karasawa
Journal:  Clin Exp Metastasis       Date:  2021-02-24       Impact factor: 5.150

6.  Synthesis and characterization of calcium phosphate loaded with Ho-166 and Sm-153: a novel biomaterial for treatment of spine metastases.

Authors:  B A Donanzam; T P R Campos; I Dalmázio; E S Valente
Journal:  J Mater Sci Mater Med       Date:  2013-08-03       Impact factor: 3.896

Review 7.  Treatment of spine metastases in cancer: a review.

Authors:  Yu Chen; Yayi He; Chao Zhao; Xuefei Li; Caicun Zhou; Fred R Hirsch
Journal:  J Int Med Res       Date:  2019-12-26       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.